By checking stability of implant and bone density around implant this study will be comparing two growth factors namely concentrated growth factor and injectable platelet rich fibrin when mixed with bone graft and used in maxillary sinus floor lifting procedure during implant surgery

An Assessment of Implant Stability and Bone Density using CGF and I-PRF in Sinus Augmentation Procedure - A Randomized Control Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057033

Enrollment

Registered

2023-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K082- Atrophy of edentulous alveolar ridge

Interventions

Intervention1: CGF: CGF will be used along with bone graft in sinus augmentation using crestal approach and after a period of six months from the day of surgery implpant stability and bone density wil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for voluntary participation & have signed informed consent for the described procedure. 2. Patients having good physical and mental health and well-formed or moderately formed residual alveolar ridge 3. Systemically healthy subjects. 4. Patients requiring Sinus augmentation prior to placement of implant. 5. Patients well motivated for implant therapy and maintaining good oral hygiene. 6. Patients requiring bilateral sinus lift

Exclusion criteria

Exclusion criteria: 1. Immunocompromised patients. 2. Grafted site (previous or during implant placement). 3. Patients of chronic and aggressive periodontitis. 4. Flapless procedures. 5. Alcohol or drug abuse. 6. Psychologically compromised patients. 7. Patients with temporomandibular disorders, severe residual ridge resorption, orofacial tumors and gross facial deformity, mucositis, radiation therapy, parafunctional habit, etc. 8. Patients with active diseases of the implant bed (e.g., residual cysts) 9. Cancer Patients (ongoing chemotherapy) 10. Patients on steroid therapy 11. Severe Metabolic Diseases 12. Immunocompromised patients 13. Abnormal Platelet Function 14. Bisphosphonates Therapy

Design outcomes

Primary

Measure	Time frame
outcome of this study will be to see the density of bone & improvement in implant stability using CGF & I-PRF in sinus augmentation, showing accelerated tissue healing and bone regeneration.Timepoint: after six mpnths post operatively	—

Secondary

Measure	Time frame
To compare implant stability & bone density between CGF and I-PRF in sinus augmentation.Timepoint: after six months post operatively	—

Countries

India

Contacts

Public ContactDr Unnati Agarwal

Sardar Patel Post graduate institute of dental and medical sciences

shitijsrivastava@gmail.com9335902531

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026